covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccines - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
fasinex super 19.5% w/v oral suspension
elanco gmbh - triclabendazole; levamisole hydrochloride - oral suspension - 19.5 percent weight/volume - anthelmintics - cattle - endoparasiticide
clindamycin and benzoyl peroxide gel
glenmark pharmaceuticals inc., usa - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - clindamycin and benzoyl peroxide gel is indicated for the topical treatment of acne vulgaris. clindamycin and benzoyl peroxide gel is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.
kyleena 19.5 mg i.uter. delivery system
bayer sa-nv - levonorgestrel 19,5 mg - intrauterine delivery system - 19,5 mg - levonorgestrel 19.5 mg - plastic iud with progestogen
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccines - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.spikevax bivalent original/omicron ba.1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19.spikevax bivalent original/omicron ba.4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb.1.5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older.the use of this vaccine should be in accordance with official recommendations.
jcovden (previously covid-19 vaccine janssen)
janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaccines - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older.the use of this vaccine should be in accordance with official recommendations.
vaxzevria (previously covid-19 vaccine astrazeneca)
astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vaccines - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older.the use of this vaccine should be in accordance with official recommendations.
kyleena 19.5 mg intrauterine delivery system
bayer limited - levonorgestrel, micronized - intrauterine delivery system - 19.5 milligram(s) - intrauterine contraceptives; plastic iud with progestogen
kyleena levonorgestrel 19.5 mg intrauterine drug delivery system sachet
bayer australia ltd - levonorgestrel, quantity: 19.5 mg - drug delivery system, intrauterine - excipient ingredients: dimethylsiloxane/methylvinylsiloxane cross linked elastomer - contraception for up to 5 years
sulfaquinoxaline 19.2% liquid concentrate solution
dominion veterinary laboratories ltd. - sulfaquinoxaline (sulfaquinoxaline sodium) - solution - 19.2% - sulfaquinoxaline (sulfaquinoxaline sodium) 19.2% - poultry; poultry